TipRanks
Advertisement
Advertisement
Regeneron says COURAGE trial confirms trevogrumab prevents muscle loss
PremiumThe FlyRegeneron says COURAGE trial confirms trevogrumab prevents muscle loss
5d ago
Exxon Mobil downgraded, BP upgraded: Wall Street’s top analyst calls
Premium
The Fly
Exxon Mobil downgraded, BP upgraded: Wall Street’s top analyst calls
5d ago
Argus upgrades Regeneron on attractive entry point after selloff
Premium
The Fly
Argus upgrades Regeneron on attractive entry point after selloff
5d ago
Kodiak data raises competitive bar for Regeneron, says Citi
PremiumThe FlyKodiak data raises competitive bar for Regeneron, says Citi
8d ago
Regeneron price target raised to $920 from $800 at HSBC
Premium
The Fly
Regeneron price target raised to $920 from $800 at HSBC
26d ago
Veeva price target raised to $310 from $270 at Needham
Premium
The Fly
Veeva price target raised to $310 from $270 at Needham
1M ago
Regeneron announces Health Canada approval of new indication for Libtayo
PremiumThe FlyRegeneron announces Health Canada approval of new indication for Libtayo
2M ago
Regeneron price target raised to $1,030 from $1,000 at Guggenheim
Premium
The Fly
Regeneron price target raised to $1,030 from $1,000 at Guggenheim
2M ago
Regeneron price target raised to $740 from $700 at Citi
Premium
The Fly
Regeneron price target raised to $740 from $700 at Citi
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―